Data backs Vasca's haemodialysis access system:
This article was originally published in Clinica
Vasca says that a multicentre clinical study has shown that patients using its LifeSite haemodialysis access system experienced significantly fewer device-related adverse events and complications during a 12-month follow-up period than those using a standard haemodialysis catheter. Patients treated with the LifeSite system were also significantly more likely to still be using the device a year later than those using the standard catheter, says the Tewksbury, Massachusetts firm. The LifeSite device is a totally subcutaneous haemodialysis access system. It was cleared for sale in the US in 2000.
You may also be interested in...
According to the plaintiff, Unilever’s Pond’s Rejuveness Anti-Wrinkle Cream is defective insofar as tested product has been found to contain unlabeled mercury, constituting negligence that has resulted in user injuries. The plaintiff seeks certification of a transnational class and compensatory and punitive damages, among other relief.
HBW Product Launches: New Chapter Collagen, Alkamind Acid-Kicking, GNC China, Tetra Bio Canada, More
GNC, Harbin launch supplements in China following regulatory approval; Bee Gone expands with allergy swabs; Bed, Bath & Beyond expands distribution of CBDMedic personal care products promoted by Rob Gronkowski; Tetra Bio has Canadian OK For hemorrhoid and pain relief OTCs, US and European pending; Agrozen offers Urban Daze CBD products; New Chapter portfolio expansion also includes fermented vitamins, elderberry supplements and magnesium; and Alkamind’s Acid-Kicking Coffee Alkalizer creamers help neutralize acid from coffee.
In joint complaint, the FTC and New York Attorney General allege scheme to block generic Daraprim and maintain exorbitant list price; they cite hundreds of emails the incarcerated Shkreli has exchanged with co-defendant in last six months.